Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 5,141 | 3,824 | 6,783 | 3,820 | 3,016 |
| Cost of Goods | 2,082 | 838 | 2,846 | 1,710 | 1,507 |
| Gross Profit | 3,059 | 2,986 | 3,937 | 2,110 | 1,509 |
| Operating Expenses | 9,756 | 10,201 | 9,517 | 7,685 | 5,934 |
| Operating Income | -6,615 | -6,377 | -4,734 | -4,865 | -3,918 |
| Other Income | -1,136 | -576 | -666 | -148 | 54 |
| Pre-tax Income | -7,751 | -6,953 | -5,400 | -5,013 | -3,864 |
| Net Income Continuous | -7,751 | -6,953 | -5,400 | -5,013 | -3,864 |
| Minority Interests | -69 | N/A | N/A | N/A | N/A |
| Net Income | $-7,682 | $-6,893 | $-5,400 | $-5,013 | $-3,864 |
| EPS Basic Total Ops | -0.52 | -0.58 | -0.49 | -0.55 | -0.45 |
| EPS Basic Continuous Ops | -0.53 | -0.57 | -0.49 | -0.55 | -0.45 |
| EPS Diluted Total Ops | -0.52 | -0.58 | -0.49 | -0.55 | -0.45 |
| EPS Diluted Continuous Ops | -0.53 | -0.57 | -0.49 | -0.55 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.58 | -0.49 | -0.55 | -0.45 |
| EBITDA(a) | $-6,161 | $-5,935 | $-4,350 | $-4,559 | $-3,741 |